RNA-Seq in PBS- and mouse αSyn PFF-treated mouse primary cultured neurons
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1111384 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR29016167.fastq.gz | Fastqsanger.gz | |||
| SRR29016168.fastq.gz | Fastqsanger.gz | |||
| SRR29016169.fastq.gz | Fastqsanger.gz | |||
| SRR29016170.fastq.gz | Fastqsanger.gz | |||
| SRR29016171.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 6 |
Similar Datasets
Project description:The balk RNA-seq in PBS- and αSyn pre-formed fibril (PFF)-treated neurons was done to investigate the expression levels of gene transcripts enriched in both BG4- and pS129-RIP-seq (GSE234238). Analysis of RNA-seq revealed that the expression levels of these common enriched RNAs in mPFF-treated neurons were little changed in comparison to vehicle-treated neurons.
2024-10-10 | GSE267382 | GEO
Project description:Analyzing and comparing proteome profiling N40K mouse cultured neurons will be beneficial to understand the contributing of RNA splicing dysfunction pathway to Alzheimer's Disease.
2022-08-12 | PXD031546 | Pride
Project description:While there is significant progress in characterizing the pathogenesis of Parkinson's disease (PD), underlying cell biological events are less well-defined. Increasing evidence suggests that endolysosomal dysfunction is a critical driver of PD pathogenesis. In this study, we explored the impact of preformed α-synuclein fibrils (PFF) on endolysosomal function and downstream events, including activation of cellular senescence pathways. We found that PFF treatment of primary cultures of mouse cortical neurons caused widespread endolysosomal dysfunction. PFF treatment also induced changes in transcriptional reprogramming and chromatin accessibility. To define underlying mechanisms we explored the status of LRRK2, finding that PFF treatment activated LRRK2 on early endosomes where it phosphorylated Rab5. PFF also induced phosphorylation of Rab7. LRRK2 activation was necessary for endolysosomal dysfunction and transcriptional changes as these changes were prevented by pharmacological inhibition of LRRK2 with MLi-2. In addition, Rab5 changes mediated by PFF treatment contributed to changes in chromatin remodeling. These cell biological insights point to a critical role in PD pathogenesis for LRRK2 activation and its engagement of the endolysosomal network and to a novel role for the LRRK2-Rab5 axis in mediating its manifestations.
2026-05-13 | GSE294156 | GEO
Project description:Gene expression profiles in the cultured dorsal root ganglia (DRG) neurons treated with PBS or oncomodulin (ONCM)
| PRJNA798679 | ENA
Project description:boncat silac analysis of bdnf treated/untreated mouse hippocampal slices and cultured neurons
2014-11-03 | MSV000078919 | MassIVE
Project description:Illumina RNA sequencing technology was used to determine transcriptome changes in cultured mouse cortical neurons infected with lentivirus expressing shMeCP2
2017-04-06 | GSE79993 | GEO
Project description:Parkinson’s disease (PD) is characterized by neuroinflammation, progressive loss of dopaminergic neurons, and accumulation of a-synuclein (a-Syn) into insoluble aggregates called Lewy pathology. The Line 61 a-Syn mouse is an established preclinical model of PD; Thy-1 is used to promote human a-Syn expression, and features of sporadic PD develop at 9-18 months of age. To accelerate the PD phenotypes, we injected sonicated human a-Syn preformed fibrils (PFFs) into the striatum, which produced phospho-Syn (p-a-Syn) inclusions in the substantia nigra pars compacta and significantly increased MHC Class II-positive immune cells. Additionally, there was enhanced infiltration and activation of innate and adaptive immune cells in the midbrain. We then used this new model, Line 61-PFF, to investigate the effect of inhibiting the JAK/STAT signaling pathway, which is critical for regulation of innate and adaptive immune responses. After administration of the JAK1/2 inhibitor AZD1480, immunofluorescence staining showed a significant decrease in p-a-Syn inclusions and MHC Class II expression. Flow cytometry showed reduced infiltration of CD4+ T-cells, CD8+ T-cells, CD19+ B-cells, dendritic cells, macrophages, and endogenous microglia into the midbrain. Importantly, single-cell RNA-Sequencing analysis of CD45+ cells from the midbrain identified 9 microglia clusters, 5 monocyte/macrophage (MM) clusters, and 5 T-cell (T) clusters, in which potentially pathogenic MM4 and T3 clusters were associated with neuroinflammatory responses in Line 61-PFF mice. AZD1480 treatment reduced cell numbers and cluster-specific expression of the antigen-presentation genes H2-Eb1, H2-Aa, H2-Ab1, and Cd74 in the MM4 cluster and proinflammatory genes such as Tnf, Il1b, C1qa, and C1qc in the T3 cluster. Together, these results indicate that inhibiting the JAK/STAT pathway suppresses the activation and infiltration of innate and adaptive cells, reducing neuroinflammation in the Line 61-PFF mouse model.
2024-05-31 | GSE264525 | GEO
Project description:Parkinson's disease (PD) genetic asymmetry in SNCA PFF injected mouse model
| PRJNA1107579 | ENA
Project description:We measured gene expression in neuronal nuclei from cortex derived from both hemispheres (injected and noninjected side) of mice (16 male, 16 female) intected with either PBS or SNCA PFFs. Mice were sacrificied at either 1 or 3 month post injection. This was a preliminary experiment done to examine a mouse model of asymmetry in a PD-like condition. RNA-sequencing was used to measure gene expression differences resulting from injecting PBS or alpha-synuclein pre-formed fibrils (PFFs), an inducer of PD like neuropathy, in the right olfactory bulb of 32 (C57BL/6J) mice, 16 male and 16 female. Cortex was then isolated for RNA extraction from both right and left hemispherical cortex in all mice at either 1 month or 3-months post-injection. The overall conclusion was that expression changes were found but were too modest to warrant further focus using mice. Greater detail is given below. While the model has some value and the results may be useful for comparison with human data, nuisance variables were found to induce changes of similar magnitude to treatment conditions. The small magnitude in differential expression levels, coupled with strong effects by confounds, primarily cage to cage variation, resulted in less robust results than desirable. Thus, while this pilot experiment indicates that a few dozen to a few hundred genes may show hemispherical asymmetry in the mouse model across sex and timepoint, further experiments will focus on human data. Within the experiment the features conferring the greatest difference in overall gene expression levels between the mice were sex, followed by time post injection (1-month vs. 3-month) (figure 1,2). The conditions of interest, treatment: PBS or PFF, and hemisphere: injected vs non-injected, do not confer obvious structure to overall gene expression patterns. Rather differences between individual mice as well as between cage mates outweigh overall differences for the latter 2 experimental conditions. However, some individual genes do show significant treatment or hemispherical differential expression. This is truer when treatment or hemisphere are considered while holding sex and/or timepoint constant (Table 1). Overall, across 16 statistical comparisons, 1038 statistically significant (FDR < 0.05) and high fold change (>40% change in expression) genes. Of these, excluding simple male vs. female, 342 genes are unique. These 342 genes show enrichment in processes related to neurotransmitter function, especially dopamine, cell signaling, drug binding, complement activation of the immune system, and others. Individual comparisons are expected to be most relevant for elucidating PD asymmetry. For instance, 23 genes are significant (adj. p.value < 0.5 and logFC > 0.5) for differences between injected and non-injected hemispheres regardless of sex or timepoint. These 23 genes show some GO enrichment for axonogenesis and dopaminergic systems, among other things. It is somewhat surprising that such PD-relevant categories show differential expression in this comparison, as the PBS condition should not induce a disease like state. However, the sensitivity of the analysis may be misleading. 2/3 of the significant DE genes were also
2026-05-01 | GSE266555 | GEO